Table 2.

Unadjusted incidence rates and IRRs for cancer type, by PKD status

Cancer TypePKD RecipientsNon-PKD RecipientsIRR (95% CI)
Count (n)Incidence RateaCount (n)Incidence Ratea
Lip1325.87415.51.66 (0.88 to 2.89)
Salivary gland713.9306.32.20 (0.89 to 4.73)
Oropharynx713.9398.21.70 (0.69 to 3.56)
Other oral cavity and pharynx59.97515.70.63 (0.22 to 1.41)
Nasopharynxb0071.50
Esophagus59.9479.91.00 (0.35 to 2.29)
Stomach815.99119.10.83 (0.37 to 1.60)
Small intestine24.0194.00.99 (0.16 to 3.42)
Colon and rectum2549.632868.90.72 (0.47 to 1.06)
Anus35.95110.70.56 (0.14 to 1.51)
Liver47.95110.70.74 (0.22 to 1.81)
Intrahepatic bile duct24.030.66.30 (0.83 to 37.99)
Gallbladderb0071.50
Other biliary47.9112.33.43 (0.95 to 10.04)
Pancreas1427.88417.61.57 (0.86 to 2.68)
Larynx24.0459.40.42 (0.07 to 1.36)
Lung69136.8582122.21.12 (0.86 to 1.43)
Bones and jointsb00112.30
Soft tissue including heart815.9326.72.36 (1.01 to 4.87)
Melanoma4895.222547.22.01 (1.46 to 2.72)
Other nonepithelial skin2039.710722.51.77 (1.06 to 2.78)
Breast3773.429962.81.17 (0.82 to 1.62)
Cervixb002713.90
Uterus1253.26030.81.89 (0.97 to 3.38)
Ovary417.72613.31.45 (0.43 to 3.73)
Vaginab0084.10
Vulva626.63417.51.67 (0.63 to 3.69)
Prostate74265.6555197.21.26 (0.98 to 1.59)
Testis517.9269.21.82 (0.61 to 4.35)
Penisb00155.30
Bladder1325.814229.80.86 (0.47 to 1.47)
Kidney4997.2610128.10.76 (0.56 to 1.00)
 RCCc4589.2505106.00.84 (0.61 to 1.13)
Renal pelvis12.0153.10.63 (0.03 to 3.11)
Eye and orbit47.9122.53.15 (0.88 to 9.04)
Brain59.9296.11.63 (0.55 to 3.85)
Thyroid1631.716835.30.90 (0.52 to 1.45)
Hodgkin lymphoma59.94910.30.96 (0.33 to 2.19)
Non-Hodgkin lymphoma74146.8672141.11.04 (0.81 to 1.31)
Plasma cell neoplasms815.97315.31.03 (0.46 to 2.02)
Acute lymphocytic leukemia12.081.71.18 (0.06 to 6.44)
Chronic lymphocytic leukemia12.0142.90.67 (0.04 to 3.36)
Acute myeloid leukemia713.9367.61.84 (0.75 to 3.88)
Chronic myeloid leukemia35.9204.21.42 (0.33 to 4.13)
Acute monocytic leukemiab0010.20
Other acute leukemiab0040.80
Mesothelioma12.0122.50.79 (0.04 to 3.99)
Kaposi sarcoma611.97315.30.78 (0.30 to 1.64)
Miscellaneous3773.432768.71.07 (0.75 to 1.48)
Tumors of poorly specified morphology713.99620.20.69 (0.29 to 1.38)
All cancers, combined6221233.653301119.11.10 (1.01 to 1.20)
All cancers excluding kidney, melanoma, and nonepithelial skin5051001.64388921.31.09 (0.99 to 1.19)
  • a Incidence rate is per 100,000 person-years.

  • b Because there were no cases among PKD recipients, the Poisson regression model did not converge.

  • c RCCs are shown separately in the table, but because all were located in the kidney, they do not contribute to the total.